Non-invasive foetal RhD genotyping to guide anti-D prophylaxis: an external quality assurance workshop.
作者信息
Clausen Frederik B, Barrett Angela N, Krog Grethe R, Finning Kirstin, Dziegiel Morten H
机构信息
Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
出版信息
Blood Transfus. 2018 Jul;16(4):359-362. doi: 10.2450/2017.0329-16. Epub 2017 Apr 5.
Abstract
摘要
相似文献
1
Non-invasive foetal RhD genotyping to guide anti-D prophylaxis: an external quality assurance workshop.非侵入性胎儿RhD基因分型指导抗D预防：一次外部质量保证研讨会
Blood Transfus. 2018 Jul;16(4):359-362. doi: 10.2450/2017.0329-16. Epub 2017 Apr 5.
2
Determination of fetal RHD type in plasma of RhD negative pregnant women.RhD阴性孕妇血浆中胎儿RHD血型的测定。
Scand J Clin Lab Invest. 2018 Sep;78(5):411-416. doi: 10.1080/00365513.2018.1475681. Epub 2018 Jun 5.
3
Noninvasive fetal RhD genotyping.非侵入性胎儿RhD基因分型
Transfus Apher Sci. 2014 Apr;50(2):154-62. doi: 10.1016/j.transci.2014.02.008. Epub 2014 Mar 6.
4
Genotyping approach for non-invasive foetal RHD detection in an admixed population.用于混合人群中无创性胎儿 RHD 检测的基因分型方法。
Blood Transfus. 2017 Jan;15(1):66-73. doi: 10.2450/2016.0228-15. Epub 2016 Mar 21.
5
Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype.血清学弱D表型孕妇的风湿性心脏病基因分型的财务影响。
Transfusion. 2015 Sep;55(9):2095-103. doi: 10.1111/trf.13074. Epub 2015 Mar 21.
6
Variation in the reliability of RHD antenatal genotyping using the polymerase chain reaction and targeting multiple exons of the RHD gene.
Vox Sang. 2003 Oct;85(3):222-3. doi: 10.1046/j.1423-0410.2003.00350.x.
7
Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis.使用游离胎儿DNA进行无创胎儿RhD基因分型的诊断准确性：一项荟萃分析。
J Matern Fetal Neonatal Med. 2014 Dec;27(18):1839-44. doi: 10.3109/14767058.2014.882306. Epub 2014 Feb 10.
8
Hemolytic disease of the fetus and newborn in the molecular era.分子时代的胎儿及新生儿溶血病
Semin Fetal Neonatal Med. 2016 Feb;21(1):28-34. doi: 10.1016/j.siny.2015.10.006. Epub 2015 Nov 14.
9
Genotyping to prevent Rh disease: has the time come?基因分型预防Rh疾病：时机已到？
Curr Opin Hematol. 2017 Nov;24(6):544-550. doi: 10.1097/MOH.0000000000000379.
10
Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis.澳大利亚针对 RhD 阴性孕妇的非侵入性胎儿 RHD 基因分型用于靶向抗-D 治疗的成本效益分析。
Prenat Diagn. 2017 Dec;37(12):1245-1253. doi: 10.1002/pd.5176.
引用本文的文献
1
Fetal Screening in RH1 Negative Pregnant Women: Experience in Switzerland.RH1阴性孕妇的胎儿筛查：瑞士的经验
Biomedicines. 2023 Sep 27;11(10):2646. doi: 10.3390/biomedicines11102646.
2
Recommendation for validation and quality assurance of non-invasive prenatal testing for foetal blood groups and implications for IVD risk classification according to EU regulations.推荐用于验证和质量保证的非侵入性产前测试胎儿血型和对欧盟法规下的体外诊断试剂风险分类的影响。
Vox Sang. 2022 Feb;117(2):157-165. doi: 10.1111/vox.13172. Epub 2021 Jun 21.
本文引用的文献
1
How to evaluate PCR assays for the detection of low-level DNA.如何评估用于检测低水平DNA的聚合酶链反应（PCR）检测方法。
APMIS. 2015 Sep;123(9):731-9. doi: 10.1111/apm.12405. Epub 2015 May 25.
2
Anti-D prophylaxis: past, present and future.抗 D 预防：过去、现在与未来。
Transfus Med. 2014 Feb;24(1):1-7. doi: 10.1111/tme.12099.
3
Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark.RhD阴性孕妇血浆中胎儿RHD的常规无创产前筛查——来自丹麦的2年筛查经验
Prenat Diagn. 2014 Oct;34(10):1000-5. doi: 10.1002/pd.4419. Epub 2014 Jun 13.
4
Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification.迈向血浆中游离DNA测量的标准化：提取效率、片段大小偏差和定量的控制
Anal Bioanal Chem. 2014 Oct;406(26):6499-512. doi: 10.1007/s00216-014-7835-3. Epub 2014 May 24.
5
Noninvasive fetal RhD genotyping.非侵入性胎儿RhD基因分型
Transfus Apher Sci. 2014 Apr;50(2):154-62. doi: 10.1016/j.transci.2014.02.008. Epub 2014 Mar 6.
6
Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.抗-D的常规管理：为孕妇提供胎儿RHD基因分型的伦理依据及政策与实践综述
BMC Pregnancy Childbirth. 2014 Feb 25;14:87. doi: 10.1186/1471-2393-14-87.
7
Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD.游离胎儿RHD基因无创产前检测中的分析前条件
PLoS One. 2013 Oct 18;8(10):e76990. doi: 10.1371/journal.pone.0076990. eCollection 2013.
8
Selection of the optimal manual method of cell free fetal DNA isolation from maternal plasma.从母体血浆中分离无细胞胎儿 DNA 的最优手动方法的选择。
Clin Chem Lab Med. 2013 Jun;51(6):1185-9. doi: 10.1515/cclm-2012-0418.
9
Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality.常规产前抗 D 预防在 Rh(D)阴性妇女中的应用：针对研究设计和质量差异进行调整的荟萃分析。
PLoS One. 2012;7(2):e30711. doi: 10.1371/journal.pone.0030711. Epub 2012 Feb 3.
10
DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.母体外周血游离 DNA 测序用于唐氏综合征的检测：一项国际临床验证研究。
Genet Med. 2011 Nov;13(11):913-20. doi: 10.1097/GIM.0b013e3182368a0e.
Zotero 插件